Labcorp acquired cancer genomics company Personal Genome Diagnostics.
The addition is expected to accelerate Labcorp's liquid biopsy capabilities and expand its oncology portfolio of next-generation sequencing-based genomic profiling capabilities, the company said February 21.
The acquisition was announced Dec. 23.